US 7,261,892 B2Granted

Methods for diagnosis and treatment of epithelial-derived cancers

AssigneeCelltech R&D Limited

InventorJonathan Alexander Terrett

Life of this patent

Estimating the term…

Abstract

The present invention relates to the use of a polypeptide (CD27L) for diagnosis of epithelial-related cancers, in particular kidney cancer e.g. renal cell cancer and colorectal cancer, e.g. colon cancers, as well as in methods of treatment of such cancers.

Claims3

Dependent claims

A method for the treatment of renal cell carcinoma in a subject, which comprises administering to said subject an antibody that specifically binds to CD27L.

Dependencies are inferred from the claim text.

Facts

Application: 10/981,381Filed 4 Nov 2004 · continuation in part
Priority: 27 Nov 2001
Published: US 2005/0118656 A19 Jun 2005
Granted: 28 Aug 2007
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

G01N 33/57535
For cancer: of the large intestine, e.g. colon, rectum or anus
A61P 35/00
Antineoplastic agents
C07H 21/04
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of…: with…
G01N 33/57525
For cancer: of the liver or pancreas

Family

Application60/333,436Us provisional application · filed 27 Nov 2001
PCT/GB02/05335Parent of this continuation-in-part · filed 27 Nov 2002
US 2005/0123547 A1Pre-grant publication · published 9 Jun 2005
Application10/496,892Parent of this continuation-in-part
US 2005/0118656 A1Published application
US 7,261,892 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results